The latest closing stock price for MoonLake Immunotherapeutics as of April 25, 2025 is 39.42.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $2,758 today, roughly 3 times their original investment - a 30.31% compound annual growth rate over 5 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 58.26, which is 47.8% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 31.42, which is 20.3% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 45.37.